Martin Cross
Direktor/Vorstandsmitglied bei Nhmrc National Institute of Dementia Research
Vermögen: 14 661 $ am 30.04.2024
Profil
Martin Cross currently works at Nhmrc National Institute of Dementia Research, as Non-Executive Director.
Dr. Cross also formerly worked at Generic Medicines Industry Association Pty Ltd., as Chairman from 2010 to 2013, Medicines Australia, as Chairman from 2013 to 2015, Anagenics Ltd., as Non-Executive Director from 2017 to 2023, OncoSil Medical Ltd., as Independent Non-Executive Director from 2017 to 2022, Alphapharm Pty Ltd., as Managing Director from 2010 to 2013, Novartis Australia Pty Ltd., as Managing Director & Head-Country from 2003 to 2008, Novartis New Zealand Ltd., as Managing Director & Head-Country from 2003 to 2008, and Novartis AG, as Head-Global Marketing from 2001 to 2003.
Dr. Cross received his undergraduate degree and doctorate degree from the University of Aberdeen.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
ONCOSIL MEDICAL LTD
0,15% | 24.10.2022 | 4 510 965 ( 0,15% ) | 14 661 $ | 30.04.2024 |
Aktive Positionen von Martin Cross
Unternehmen | Position | Beginn |
---|---|---|
Nhmrc National Institute of Dementia Research | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Martin Cross
Unternehmen | Position | Ende |
---|---|---|
ANAGENICS LIMITED | Direktor/Vorstandsmitglied | 27.11.2023 |
ONCOSIL MEDICAL LIMITED | Direktor/Vorstandsmitglied | 24.10.2022 |
Medicines Australia
Medicines Australia Pharmaceuticals: MajorHealth Technology Medicines Australia is a non-profit organization which designs, develops, and implements health and industry policies for pharmaceutical industry. It builds and maintains relationships with government for fair reimbursement of medicines to ensure the continuation of a viable medicines industry, administers the Medicines Australia Code of Conduct which sets the standard for the ethical marketing and promotion of prescription medicines, and provides specialist advice to member companies. The organization is headquartered in Deakin, Australia. | Vorsitzender | 01.01.2015 |
Alphapharm Pty Ltd.
Alphapharm Pty Ltd. Pharmaceuticals: GenericHealth Technology Alphapharm has been developing and making generic medicines in Australia for more than 25 years. Millions of Australians take an Alphapharm generic medicine every day. In fact, It has become the largest supplier of medicines to the government subsidised Pharmaceutical Benefits Scheme and Australia's leader in generic medicines. Alphapharm medicines are available Australia-wide. Alphapharm medicines are made to the highest global quality standards and exported to more than 50 countries, including those in Europe and the US. Globally, Alphapharm is part of Mylan Inc., which provides products to customers in more than 140 countries and territories, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest - and highest quality - product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's third-largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies. | Vorstandsvorsitzender | 01.10.2013 |
Generic Medicines Industry Association Pty Ltd.
Generic Medicines Industry Association Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Generic Medicines Industry Association Pty Ltd. operates as a representative body of generic and biosimilar medicine suppliers in Australia. The company was founded on February 23, 2001 and is headquartered in Deakin West, Australia. | Vorsitzender | 01.01.2013 |
Ausbildung von Martin Cross
University of Aberdeen | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ANAGENICS LIMITED | Consumer Non-Durables |
NOVARTIS AG | Health Technology |
ONCOSIL MEDICAL LIMITED | Health Technology |
Private Unternehmen | 6 |
---|---|
Alphapharm Pty Ltd.
Alphapharm Pty Ltd. Pharmaceuticals: GenericHealth Technology Alphapharm has been developing and making generic medicines in Australia for more than 25 years. Millions of Australians take an Alphapharm generic medicine every day. In fact, It has become the largest supplier of medicines to the government subsidised Pharmaceutical Benefits Scheme and Australia's leader in generic medicines. Alphapharm medicines are available Australia-wide. Alphapharm medicines are made to the highest global quality standards and exported to more than 50 countries, including those in Europe and the US. Globally, Alphapharm is part of Mylan Inc., which provides products to customers in more than 140 countries and territories, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest - and highest quality - product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's third-largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies. | Health Technology |
Generic Medicines Industry Association Pty Ltd.
Generic Medicines Industry Association Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Generic Medicines Industry Association Pty Ltd. operates as a representative body of generic and biosimilar medicine suppliers in Australia. The company was founded on February 23, 2001 and is headquartered in Deakin West, Australia. | Commercial Services |
Novartis Australia Pty Ltd.
Novartis Australia Pty Ltd. BiotechnologyHealth Technology Novartis Australia Pty Ltd. engages in the marketing and wholesale of pharmaceutical products in Australia. The company is headquartered in North Ryde, Australia. | Health Technology |
Novartis New Zealand Ltd.
Novartis New Zealand Ltd. Medical DistributorsDistribution Services Novartis New Zealand Ltd. engages in the import, marketing and wholesale of pharmaceutical and animal health products. The company is headquartered in Auckland, New Zealand. | Distribution Services |
Medicines Australia
Medicines Australia Pharmaceuticals: MajorHealth Technology Medicines Australia is a non-profit organization which designs, develops, and implements health and industry policies for pharmaceutical industry. It builds and maintains relationships with government for fair reimbursement of medicines to ensure the continuation of a viable medicines industry, administers the Medicines Australia Code of Conduct which sets the standard for the ethical marketing and promotion of prescription medicines, and provides specialist advice to member companies. The organization is headquartered in Deakin, Australia. | Health Technology |
Nhmrc National Institute of Dementia Research |